Investigation announced by Kirby McInerney LLP into Soleno Therapeutics, Inc.

Kirby McInerney LLP has initiated an investigation into potential securities fraud on behalf of investors in SLNO. The New York-based law firm is looking into whether there have been any violations of federal securities laws by SLNO, a pharmaceutical company. This investigation comes after SLNO recently disclosed in a regulatory filing that it had received a subpoena from the US Department of Justice related to its marketing and promotional practices.

SLNO is a company that focuses on developing and commercializing innovative therapies for patients suffering from neurological and psychiatric disorders. The company’s most advanced product candidate is currently in clinical trials for the treatment of certain types of depression.

The investigation by Kirby McInerney LLP will focus on whether SLNO and its executives have made any false or misleading statements to investors regarding the company’s business, operations, and prospects. This includes examining whether SLNO failed to disclose any material information that could have a significant impact on the company’s stock price.

Investigations into potential securities fraud are not uncommon, as regulatory authorities and law firms work to protect investors and maintain the integrity of the financial markets. Investors rely on accurate and timely information to make informed decisions about their investments, and any false or misleading statements can have serious consequences for both the company and its shareholders.

If it is determined that SLNO did engage in securities fraud, affected investors may be entitled to recover damages. These damages could include compensation for any losses incurred as a result of the alleged fraud. It is important for investors who believe they may have been harmed by securities fraud to seek legal advice to understand their rights and options for potential recovery.

As the investigation into SLNO continues, Kirby McInerney LLP will work to uncover any evidence of wrongdoing and hold those responsible accountable. The firm has a track record of success in securities fraud cases and is committed to fighting for the rights of investors who have been harmed by fraudulent practices.

Investors who have purchased shares of SLNO and have concerns about their investment are encouraged to contact Kirby McInerney LLP for more information about the investigation and their rights. The firm will provide updates on the investigation as it progresses and will work to ensure that investors receive fair treatment and compensation for any losses they may have suffered.